Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Extension of Comment Period

摘要

The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry" that appeared in the Federal Register of October 25, 2019. The Agency is taking this action to allow interested persons additional time to submit comments.